Literature DB >> 21762287

Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats.

Eric P Zorrilla1, Sunmee Wee, Yu Zhao, Sheila Specio, Benjamin Boutrel, George F Koob, Friedbert Weiss.   

Abstract

Cocaine-induced neuroadaptation of stress-related circuitry and increased access to cocaine each putatively contribute to the transition from cocaine use to cocaine dependence. The present study tested the hypothesis that rats receiving extended versus brief daily access to cocaine would exhibit regional differences in levels of the stress-regulatory neuropeptide corticotropin-releasing factor (CRF). A secondary goal was to explore how CRF levels change in relation to the time since cocaine self-administration. Male Wistar rats acquired operant self-administration of cocaine and were assigned to receive daily long access (6 hours/day, LgA, n=20) or short access (1 hour/day, ShA, n=18) to intravenous cocaine self-administration (fixed ratio 1, ~0.50 mg/kg/infusion). After at least 3 weeks, tissue CRF immunoreactivity was measured at one of three timepoints: pre-session, post-session or 3 hours post-session. LgA, but not ShA, rats showed increased total session and first-hour cocaine intake. CRF immunoreactivity increased within the dorsal raphe (DR) and basolateral, but not central, nucleus of the amygdala (BLA, CeA) of ShA rats from pre-session to 3 hours post-session. In LgA rats, CRF immunoreactivity increased from pre-session to 3 hours post-session within the CeA and DR but tended to decrease in the BLA. LgA rats showed higher CRF levels than ShA rats in the DR and, pre-session, in the BLA. Thus, voluntary cocaine intake engages stress-regulatory CRF systems of the DR and amygdala. Increased availability of cocaine promotes greater tissue CRF levels in these extrahypothalamic brain regions, changes associated here with a model of cocaine dependence.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762287      PMCID: PMC3304464          DOI: 10.1111/j.1369-1600.2011.00329.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  59 in total

1.  Long-lasting increase in the set point for cocaine self-administration after escalation in rats.

Authors:  S H Ahmed; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

2.  Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system.

Authors:  C A Lowry; J E Rodda; S L Lightman; C D Ingram
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats.

Authors:  N E Goeders; G F Guerin
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

4.  Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.

Authors:  L G Kirby; K C Rice; R J Valentino
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

5.  Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

Authors:  K H Skelton; C B Nemeroff; D L Knight; M J Owens
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

6.  Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.

Authors:  T J Sajdyk; D R Gehlert
Journal:  Brain Res       Date:  2000-09-22       Impact factor: 3.252

7.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.

Authors:  D T Chalmers; T W Lovenberg; E B De Souza
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

8.  Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.

Authors:  Y Zhou; R Spangler; K S LaForge; C E Maggos; A Ho; M J Kreek
Journal:  J Pharmacol Exp Ther       Date:  1996-10       Impact factor: 4.030

9.  Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats.

Authors:  Z Sarnyai; E Bíró; J Gardi; M Vecsernyés; J Julesz; G Telegdy
Journal:  Brain Res       Date:  1993-07-09       Impact factor: 3.252

10.  Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.

Authors:  Z Sarnyai; E Bíró; J Gardi; M Vecsernyés; J Julesz; G Telegdy
Journal:  Brain Res       Date:  1995-03-27       Impact factor: 3.252

View more
  15 in total

Review 1.  Corticotropin releasing factor: a key role in the neurobiology of addiction.

Authors:  Eric P Zorrilla; Marian L Logrip; George F Koob
Journal:  Front Neuroendocrinol       Date:  2014-01-20       Impact factor: 8.606

2.  Coordinate regulation of noradrenergic and serotonergic brain regions by amygdalar neurons.

Authors:  T A Retson; E J Van Bockstaele
Journal:  J Chem Neuroanat       Date:  2013-05-04       Impact factor: 3.052

3.  The duration of intermittent access to preferred sucrose-rich food affects binge-like intake, fat accumulation, and fasting glucose in male rats.

Authors:  A D Kreisler; M Mattock; E P Zorrilla
Journal:  Appetite       Date:  2018-07-29       Impact factor: 3.868

Review 4.  Modeling the development of drug addiction in male and female animals.

Authors:  Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2017-06-15       Impact factor: 3.533

5.  Escalated cocaine "binges" in rats: enduring effects of social defeat stress or intra-VTA CRF.

Authors:  Michael Z Leonard; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2017-07-18       Impact factor: 4.530

6.  Hold-down as an alternative to unit dose in cocaine self-administration experiments: Characterization using a progressive ratio schedule.

Authors:  David C S Roberts; Benjamin A Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2020-05-28       Impact factor: 4.530

7.  Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.

Authors:  Brooke E Schmeichel; Melissa A Herman; Marisa Roberto; George F Koob
Journal:  Biol Psychiatry       Date:  2016-06-16       Impact factor: 13.382

8.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

9.  A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.

Authors:  Choon-Gon Jang; Timothy Whitfield; Gery Schulteis; George F Koob; Sunmee Wee
Journal:  Psychopharmacology (Berl)       Date:  2012-09-25       Impact factor: 4.530

10.  Cocaine-induced membrane adaptation in the central nucleus of amygdala.

Authors:  Bo Chen; Yao-Ying Ma; Yao Wang; Xiusong Wang; Oliver M Schlüter; Yan Dong; Yanhua H Huang
Journal:  Neuropsychopharmacology       Date:  2013-05-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.